The Technical Analyst
Select Language :
Mirati Therapeutics Inc [MRTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Mirati Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Mirati Therapeutics Inc is listed at the  Exchange

-0.17% $58.70

America/New_York / 22 jan 2024 @ 16:00


Mirati Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 4 117.67 mill
EPS: -12.18
P/E: -4.82
Earnings Date: Feb 26, 2024
SharesOutstanding: 70.15 mill
Avg Daily Volume: 1.779 mill
RATING 2024-01-22
B-
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
2/223/224/221/232/233/23
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -4.82 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.82x
Company: PE -4.82 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 58.22 - 59.19

( +/- 0.83%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2024-01-23 Boxer Capital, Llc Sell 30 518 Common Stock
2024-01-23 Boxer Capital, Llc Sell 1 413 475 Warrant (right to purchase)
2024-01-23 Sharp Shalini Sell 4 162 Common Stock
2024-01-23 Sharp Shalini Sell 5 252 Common Stock
2024-01-23 Sharp Shalini Sell 6 808 Common Stock
INSIDER POWER
-93.84
Last 100 transactions
Buy: 125 442 | Sell: 3 801 194

Forecast: 01:40 - $64.47

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $58.70 (-0.17% )
Volume 20.96 mill
Avg. Vol. 1.779 mill
% of Avg. Vol 1 178.27 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Mirati Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Mirati Therapeutics Inc

RSI

Intraday RSI14 chart for Mirati Therapeutics Inc

Last 10 Buy & Sell Signals For MRTX

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Mirati Therapeutics Inc

MRTX

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; and Sitravatinib, an investigational spectrum-selective kinase inhibitor that is in Phase 3 clinical trial for the treatment of NSCL cancer, as well as a KRAS G12D inhibitor program, which is in preclinical development. It has a collaboration and license agreement with BeiGene, Ltd. to develop, manufacture, and commercialize sitravatinib. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
SOON.OLMar 27 - 08:05NOK67.00
ELO.OLMar 27 - 08:05NOK34.00
VEI.OLMar 27 - 08:05NOK118.00
RIVER.OLMar 27 - 08:0527.00
MAS.OLMar 27 - 08:0530.30
NAVA.OLMar 27 - 07:58NOK35.60
CARA.OLMar 27 - 08:05NOK11.52
NOL.OLMar 27 - 08:09NOK9.97
OLT.OLMar 27 - 08:05NOK222.00
ANTUSDMar 28 - 04:37$9.04

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.